Galderma Agrees to a $990,000 Settlement Over Alleged Benzene Contamination in Differin Acne Products
Galderma Laboratories has agreed to a $990,000 settlement to resolve a class action lawsuit alleging that certain Differin branded benzoyl peroxide acne treatments were potentially contaminated with benzene, a well known carcinogen. The settlement received preliminary court approval on February…
